Hyperuricemic effects of cholinergic agents in rats

Area of Science:

• Pharmacology
• Biochemistry
• Physiology

Background:

• Cholinergic agents are known to influence various physiological processes.
• The precise mechanism by which cholinergic agents affect uric acid levels remains incompletely understood.

Purpose of the Study:

• To investigate the hyperuricemic effect of cholinergic agents in rats.
• To elucidate the underlying mechanisms of cholinergic agent-induced hyperuricemia, focusing on uric acid production.

Main Methods:

• Utilized potassium oxonate to inhibit urate oxidase in rats, inducing hyperuricemia.
• Employed functionally hepatectomized and eviscerated rats to assess the role of the liver and gastrointestinal tract.
• Administered cholinergic agents (acetylcholine, physostigmine, carbachol) and antagonists (methylatropine, hexamethonium) to evaluate their effects on plasma uric acid levels.
• Investigated the impact of nephrectomy and allopurinol treatment on cholinergic agent-induced hyperuricemia.

Main Results:

• Cholinergic agents, particularly carbachol and physostigmine-potentiated acetylcholine, significantly increased plasma uric acid levels.
• The hyperuricemic effect was observed even in eviscerated rats, indicating a non-hepatic and non-gastrointestinal origin.
• Nephrectomy exacerbated the hyperuricemic response, while methylatropine, but not hexamethonium, abolished it.
• Allopurinol treatment prevented carbachol-induced hyperuricemia when plasma uric acid was maintained exogenously.

Conclusions:

• Cholinergic agents induce hyperuricemia primarily by stimulating uric acid production.
• Uric acid production in tissues beyond the liver and gastrointestinal tract is crucial for the induction of hyperuricemia by cholinergic agents.
• The findings suggest a complex interplay between cholinergic signaling, uric acid synthesis, and renal function.